Loading the SOTA2 catalog…
SFA Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing oral immune tolerance therapies for psoriasis and other autoimmune and oncology indications using a proprietary deuterated short-chain fatty acid platform.
- Founded
- Not disclosed
- Headquarters
- Not disclosed
- Company size
- 1–10
- Products tracked
- 3
Products by SFA Therapeutics, Inc.
Pricing for SFA Therapeutics, Inc.
Contact sales
Contact SFA Therapeutics, Inc. for current plans, volume pricing, and enterprise terms.
Trust profile
Security and compliance
No compliance claims have been published for this company.